nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2E1—Sulfadiazine—malaria	0.0557	0.0747	CbGbCtD
Etoricoxib—CYP2E1—Proguanil—malaria	0.0445	0.0598	CbGbCtD
Etoricoxib—PTGS2—Dapsone—malaria	0.0333	0.0447	CbGbCtD
Etoricoxib—CYP2C19—Artemether—malaria	0.0297	0.0398	CbGbCtD
Etoricoxib—CYP3A4—Clindamycin—malaria	0.0294	0.0394	CbGbCtD
Etoricoxib—CYP2C9—Pyrimethamine—malaria	0.029	0.039	CbGbCtD
Etoricoxib—CYP2C9—Sulfadiazine—malaria	0.029	0.039	CbGbCtD
Etoricoxib—CYP2E1—Quinine—malaria	0.0287	0.0385	CbGbCtD
Etoricoxib—CYP2C19—Proguanil—malaria	0.0279	0.0375	CbGbCtD
Etoricoxib—CYP2D6—Pyrimethamine—malaria	0.0265	0.0356	CbGbCtD
Etoricoxib—CYP1A2—Proguanil—malaria	0.0257	0.0346	CbGbCtD
Etoricoxib—CYP2E1—Quinidine—malaria	0.0252	0.0338	CbGbCtD
Etoricoxib—CYP2C9—Artemether—malaria	0.0247	0.0331	CbGbCtD
Etoricoxib—CYP2C9—Proguanil—malaria	0.0232	0.0311	CbGbCtD
Etoricoxib—CYP2D6—Artemether—malaria	0.0226	0.0303	CbGbCtD
Etoricoxib—CYP2E1—Dapsone—malaria	0.0217	0.0292	CbGbCtD
Etoricoxib—CYP2D6—Proguanil—malaria	0.0212	0.0285	CbGbCtD
Etoricoxib—CYP2D6—Quinidine barbiturate—malaria	0.0201	0.027	CbGbCtD
Etoricoxib—CYP1A2—Pentoxifylline—malaria	0.0185	0.0248	CbGbCtD
Etoricoxib—CYP2C19—Quinine—malaria	0.018	0.0241	CbGbCtD
Etoricoxib—CYP3A4—Sulfadiazine—malaria	0.0169	0.0226	CbGbCtD
Etoricoxib—CYP1A2—Quinine—malaria	0.0166	0.0223	CbGbCtD
Etoricoxib—CYP2C9—Quinine—malaria	0.0149	0.0201	CbGbCtD
Etoricoxib—CYP1A2—Quinidine—malaria	0.0146	0.0196	CbGbCtD
Etoricoxib—CYP3A4—Artemether—malaria	0.0143	0.0193	CbGbCtD
Etoricoxib—CYP2D6—Quinine—malaria	0.0137	0.0183	CbGbCtD
Etoricoxib—CYP2C19—Dapsone—malaria	0.0136	0.0183	CbGbCtD
Etoricoxib—CYP3A4—Proguanil—malaria	0.0135	0.0181	CbGbCtD
Etoricoxib—CYP2C9—Quinidine—malaria	0.0131	0.0176	CbGbCtD
Etoricoxib—CYP3A4—Doxycycline—malaria	0.0128	0.0172	CbGbCtD
Etoricoxib—CYP2D6—Quinidine—malaria	0.012	0.0161	CbGbCtD
Etoricoxib—CYP2C9—Dapsone—malaria	0.0113	0.0152	CbGbCtD
Etoricoxib—CYP3A4—Quinine—malaria	0.00869	0.0117	CbGbCtD
Etoricoxib—CYP3A4—Quinidine—malaria	0.00764	0.0103	CbGbCtD
Etoricoxib—CYP3A4—Dapsone—malaria	0.00659	0.00884	CbGbCtD
Etoricoxib—MAPK14—blood plasma—malaria	0.00496	0.0958	CbGeAlD
Etoricoxib—MAPK14—hematopoietic system—malaria	0.00274	0.053	CbGeAlD
Etoricoxib—MAPK14—kidney—malaria	0.00225	0.0434	CbGeAlD
Etoricoxib—CYP2C19—blood plasma—malaria	0.00211	0.0407	CbGeAlD
Etoricoxib—MAPK14—digestive system—malaria	0.00191	0.0368	CbGeAlD
Etoricoxib—MAPK14—blood—malaria	0.00182	0.0351	CbGeAlD
Etoricoxib—MAPK14—bone marrow—malaria	0.00176	0.034	CbGeAlD
Etoricoxib—CYP1A2—blood plasma—malaria	0.00172	0.0333	CbGeAlD
Etoricoxib—CYP2C9—blood plasma—malaria	0.00163	0.0316	CbGeAlD
Etoricoxib—PTGS2—endothelium—malaria	0.00161	0.031	CbGeAlD
Etoricoxib—CYP2E1—blood plasma—malaria	0.00155	0.0299	CbGeAlD
Etoricoxib—PTGS2—blood plasma—malaria	0.00143	0.0275	CbGeAlD
Etoricoxib—MAPK14—liver—malaria	0.00142	0.0274	CbGeAlD
Etoricoxib—CYP3A4—blood plasma—malaria	0.00125	0.0241	CbGeAlD
Etoricoxib—CYP2D6—blood plasma—malaria	0.00123	0.0237	CbGeAlD
Etoricoxib—CYP2C19—hematopoietic system—malaria	0.00117	0.0225	CbGeAlD
Etoricoxib—MAPK14—brain—malaria	0.00113	0.0218	CbGeAlD
Etoricoxib—CYP1A2—hematopoietic system—malaria	0.000952	0.0184	CbGeAlD
Etoricoxib—CYP2C9—hematopoietic system—malaria	0.000903	0.0175	CbGeAlD
Etoricoxib—CYP2E1—hematopoietic system—malaria	0.000856	0.0165	CbGeAlD
Etoricoxib—CYP2C19—digestive system—malaria	0.00081	0.0157	CbGeAlD
Etoricoxib—PTGS2—hematopoietic system—malaria	0.000788	0.0152	CbGeAlD
Etoricoxib—CYP2C19—blood—malaria	0.000772	0.0149	CbGeAlD
Etoricoxib—CYP2E1—kidney—malaria	0.000702	0.0136	CbGeAlD
Etoricoxib—CYP3A4—hematopoietic system—malaria	0.000689	0.0133	CbGeAlD
Etoricoxib—CYP2D6—hematopoietic system—malaria	0.000678	0.0131	CbGeAlD
Etoricoxib—CYP1A2—digestive system—malaria	0.000662	0.0128	CbGeAlD
Etoricoxib—PTGS2—kidney—malaria	0.000646	0.0125	CbGeAlD
Etoricoxib—CYP1A2—blood—malaria	0.00063	0.0122	CbGeAlD
Etoricoxib—CYP2C9—digestive system—malaria	0.000628	0.0121	CbGeAlD
Etoricoxib—CYP2C19—liver—malaria	0.000604	0.0117	CbGeAlD
Etoricoxib—CYP2C9—blood—malaria	0.000598	0.0116	CbGeAlD
Etoricoxib—CYP2E1—digestive system—malaria	0.000595	0.0115	CbGeAlD
Etoricoxib—CYP2E1—blood—malaria	0.000567	0.011	CbGeAlD
Etoricoxib—CYP3A4—kidney—malaria	0.000565	0.0109	CbGeAlD
Etoricoxib—CYP2D6—kidney—malaria	0.000556	0.0107	CbGeAlD
Etoricoxib—PTGS2—digestive system—malaria	0.000548	0.0106	CbGeAlD
Etoricoxib—PTGS2—blood—malaria	0.000522	0.0101	CbGeAlD
Etoricoxib—PTGS2—bone marrow—malaria	0.000505	0.00976	CbGeAlD
Etoricoxib—CYP1A2—liver—malaria	0.000493	0.00953	CbGeAlD
Etoricoxib—CYP3A4—digestive system—malaria	0.000479	0.00926	CbGeAlD
Etoricoxib—CYP2D6—digestive system—malaria	0.000471	0.00911	CbGeAlD
Etoricoxib—CYP2C9—liver—malaria	0.000468	0.00904	CbGeAlD
Etoricoxib—CYP3A4—blood—malaria	0.000456	0.00882	CbGeAlD
Etoricoxib—CYP2D6—blood—malaria	0.000449	0.00868	CbGeAlD
Etoricoxib—CYP2E1—liver—malaria	0.000443	0.00857	CbGeAlD
Etoricoxib—PTGS2—liver—malaria	0.000408	0.00789	CbGeAlD
Etoricoxib—CYP3A4—liver—malaria	0.000357	0.0069	CbGeAlD
Etoricoxib—CYP2E1—brain—malaria	0.000352	0.0068	CbGeAlD
Etoricoxib—CYP2D6—liver—malaria	0.000351	0.00679	CbGeAlD
Etoricoxib—Visual impairment—Quinine—malaria	0.000334	0.00206	CcSEcCtD
Etoricoxib—Thrombocytopenia—Sulfadiazine—malaria	0.00033	0.00203	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Pentoxifylline—malaria	0.000329	0.00202	CcSEcCtD
Etoricoxib—Epistaxis—Pentoxifylline—malaria	0.000328	0.00202	CcSEcCtD
Etoricoxib—Flushing—Clindamycin—malaria	0.000328	0.00202	CcSEcCtD
Etoricoxib—Erythema multiforme—Quinine—malaria	0.000328	0.00202	CcSEcCtD
Etoricoxib—Erythema multiforme—Quinidine—malaria	0.000328	0.00202	CcSEcCtD
Etoricoxib—Eye disorder—Quinine—malaria	0.000324	0.00199	CcSEcCtD
Etoricoxib—Eye disorder—Quinidine—malaria	0.000324	0.00199	CcSEcCtD
Etoricoxib—PTGS2—brain—malaria	0.000324	0.00626	CbGeAlD
Etoricoxib—Tinnitus—Quinidine—malaria	0.000323	0.00199	CcSEcCtD
Etoricoxib—Tinnitus—Quinine—malaria	0.000323	0.00199	CcSEcCtD
Etoricoxib—Vomiting—Proguanil—malaria	0.000323	0.00199	CcSEcCtD
Etoricoxib—Flushing—Quinidine—malaria	0.000322	0.00198	CcSEcCtD
Etoricoxib—Flushing—Quinine—malaria	0.000322	0.00198	CcSEcCtD
Etoricoxib—Cardiac disorder—Quinidine—malaria	0.000322	0.00198	CcSEcCtD
Etoricoxib—Cardiac disorder—Quinine—malaria	0.000322	0.00198	CcSEcCtD
Etoricoxib—Anorexia—Sulfadiazine—malaria	0.000321	0.00198	CcSEcCtD
Etoricoxib—Rash—Proguanil—malaria	0.00032	0.00197	CcSEcCtD
Etoricoxib—Dermatitis—Proguanil—malaria	0.00032	0.00197	CcSEcCtD
Etoricoxib—Headache—Proguanil—malaria	0.000318	0.00196	CcSEcCtD
Etoricoxib—Erythema—Dapsone—malaria	0.000318	0.00196	CcSEcCtD
Etoricoxib—Haemoglobin—Quinidine barbiturate—malaria	0.000315	0.00193	CcSEcCtD
Etoricoxib—Haemoglobin—Pentoxifylline—malaria	0.000314	0.00193	CcSEcCtD
Etoricoxib—Immune system disorder—Quinidine—malaria	0.000313	0.00193	CcSEcCtD
Etoricoxib—Immune system disorder—Quinine—malaria	0.000313	0.00193	CcSEcCtD
Etoricoxib—Haemorrhage—Quinidine barbiturate—malaria	0.000313	0.00192	CcSEcCtD
Etoricoxib—Hepatitis—Quinidine barbiturate—malaria	0.000313	0.00192	CcSEcCtD
Etoricoxib—Mediastinal disorder—Quinidine—malaria	0.000312	0.00192	CcSEcCtD
Etoricoxib—Mediastinal disorder—Quinine—malaria	0.000312	0.00192	CcSEcCtD
Etoricoxib—Hepatitis—Pentoxifylline—malaria	0.000312	0.00192	CcSEcCtD
Etoricoxib—Haemorrhage—Pentoxifylline—malaria	0.000312	0.00192	CcSEcCtD
Etoricoxib—Hallucination—Quinidine barbiturate—malaria	0.000311	0.00192	CcSEcCtD
Etoricoxib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000309	0.0019	CcSEcCtD
Etoricoxib—Erythema—Clindamycin—malaria	0.000308	0.00189	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000307	0.00189	CcSEcCtD
Etoricoxib—Urethral disorder—Quinidine barbiturate—malaria	0.000307	0.00189	CcSEcCtD
Etoricoxib—Insomnia—Sulfadiazine—malaria	0.000305	0.00188	CcSEcCtD
Etoricoxib—Mental disorder—Quinidine—malaria	0.000304	0.00187	CcSEcCtD
Etoricoxib—Mental disorder—Quinine—malaria	0.000304	0.00187	CcSEcCtD
Etoricoxib—Flatulence—Clindamycin—malaria	0.000303	0.00186	CcSEcCtD
Etoricoxib—Malnutrition—Quinine—malaria	0.000302	0.00186	CcSEcCtD
Etoricoxib—Malnutrition—Quinidine—malaria	0.000302	0.00186	CcSEcCtD
Etoricoxib—Erythema—Quinidine—malaria	0.000302	0.00186	CcSEcCtD
Etoricoxib—Erythema—Quinine—malaria	0.000302	0.00186	CcSEcCtD
Etoricoxib—Nausea—Proguanil—malaria	0.000302	0.00186	CcSEcCtD
Etoricoxib—Visual impairment—Quinidine barbiturate—malaria	0.000302	0.00185	CcSEcCtD
Etoricoxib—Dysgeusia—Clindamycin—malaria	0.000301	0.00185	CcSEcCtD
Etoricoxib—Vision blurred—Dapsone—malaria	0.0003	0.00184	CcSEcCtD
Etoricoxib—Erythema multiforme—Quinidine barbiturate—malaria	0.000296	0.00182	CcSEcCtD
Etoricoxib—Muscle spasms—Clindamycin—malaria	0.000296	0.00182	CcSEcCtD
Etoricoxib—Decreased appetite—Sulfadiazine—malaria	0.000293	0.0018	CcSEcCtD
Etoricoxib—Eye disorder—Quinidine barbiturate—malaria	0.000292	0.0018	CcSEcCtD
Etoricoxib—Tinnitus—Quinidine barbiturate—malaria	0.000292	0.00179	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000291	0.00179	CcSEcCtD
Etoricoxib—Cardiac disorder—Quinidine barbiturate—malaria	0.00029	0.00179	CcSEcCtD
Etoricoxib—Flushing—Quinidine barbiturate—malaria	0.00029	0.00179	CcSEcCtD
Etoricoxib—Flushing—Pentoxifylline—malaria	0.00029	0.00178	CcSEcCtD
Etoricoxib—Vision blurred—Quinidine—malaria	0.000284	0.00175	CcSEcCtD
Etoricoxib—Vision blurred—Quinine—malaria	0.000284	0.00175	CcSEcCtD
Etoricoxib—Anaemia—Clindamycin—malaria	0.000284	0.00175	CcSEcCtD
Etoricoxib—Tremor—Quinine—malaria	0.000283	0.00174	CcSEcCtD
Etoricoxib—Tremor—Quinidine—malaria	0.000283	0.00174	CcSEcCtD
Etoricoxib—Immune system disorder—Quinidine barbiturate—malaria	0.000283	0.00174	CcSEcCtD
Etoricoxib—Immune system disorder—Pentoxifylline—malaria	0.000282	0.00174	CcSEcCtD
Etoricoxib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000282	0.00173	CcSEcCtD
Etoricoxib—Arrhythmia—Pentoxifylline—malaria	0.000279	0.00172	CcSEcCtD
Etoricoxib—CYP2D6—brain—malaria	0.000279	0.00538	CbGeAlD
Etoricoxib—Cough—Dapsone—malaria	0.000278	0.00171	CcSEcCtD
Etoricoxib—Agitation—Quinidine—malaria	0.000277	0.00171	CcSEcCtD
Etoricoxib—Agitation—Quinine—malaria	0.000277	0.00171	CcSEcCtD
Etoricoxib—Angioedema—Quinine—malaria	0.000276	0.0017	CcSEcCtD
Etoricoxib—Angioedema—Quinidine—malaria	0.000276	0.0017	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Sulfadiazine—malaria	0.000276	0.0017	CcSEcCtD
Etoricoxib—Mental disorder—Quinidine barbiturate—malaria	0.000274	0.00169	CcSEcCtD
Etoricoxib—Erythema—Quinidine barbiturate—malaria	0.000272	0.00168	CcSEcCtD
Etoricoxib—Malnutrition—Quinidine barbiturate—malaria	0.000272	0.00168	CcSEcCtD
Etoricoxib—Erythema—Pentoxifylline—malaria	0.000272	0.00167	CcSEcCtD
Etoricoxib—Flatulence—Pentoxifylline—malaria	0.000268	0.00165	CcSEcCtD
Etoricoxib—Urticaria—Sulfadiazine—malaria	0.000268	0.00165	CcSEcCtD
Etoricoxib—Palpitations—Quinine—malaria	0.000267	0.00164	CcSEcCtD
Etoricoxib—Palpitations—Quinidine—malaria	0.000267	0.00164	CcSEcCtD
Etoricoxib—Abdominal pain—Sulfadiazine—malaria	0.000267	0.00164	CcSEcCtD
Etoricoxib—Dysgeusia—Pentoxifylline—malaria	0.000266	0.00164	CcSEcCtD
Etoricoxib—Hypertension—Clindamycin—malaria	0.000266	0.00163	CcSEcCtD
Etoricoxib—Muscle spasms—Pentoxifylline—malaria	0.000261	0.00161	CcSEcCtD
Etoricoxib—Chest pain—Quinidine—malaria	0.000257	0.00158	CcSEcCtD
Etoricoxib—Chest pain—Quinine—malaria	0.000257	0.00158	CcSEcCtD
Etoricoxib—Vision blurred—Quinidine barbiturate—malaria	0.000257	0.00158	CcSEcCtD
Etoricoxib—Vision blurred—Pentoxifylline—malaria	0.000256	0.00158	CcSEcCtD
Etoricoxib—Tremor—Quinidine barbiturate—malaria	0.000255	0.00157	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000255	0.00157	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000255	0.00157	CcSEcCtD
Etoricoxib—Tremor—Pentoxifylline—malaria	0.000255	0.00157	CcSEcCtD
Etoricoxib—Anaemia—Pentoxifylline—malaria	0.000251	0.00155	CcSEcCtD
Etoricoxib—Anaphylactic shock—Clindamycin—malaria	0.000251	0.00154	CcSEcCtD
Etoricoxib—Agitation—Quinidine barbiturate—malaria	0.00025	0.00154	CcSEcCtD
Etoricoxib—Agitation—Pentoxifylline—malaria	0.00025	0.00154	CcSEcCtD
Etoricoxib—Angioedema—Quinidine barbiturate—malaria	0.000249	0.00153	CcSEcCtD
Etoricoxib—Angioedema—Pentoxifylline—malaria	0.000248	0.00153	CcSEcCtD
Etoricoxib—Hypersensitivity—Sulfadiazine—malaria	0.000248	0.00153	CcSEcCtD
Etoricoxib—Confusional state—Quinine—malaria	0.000248	0.00153	CcSEcCtD
Etoricoxib—Confusional state—Quinidine—malaria	0.000248	0.00153	CcSEcCtD
Etoricoxib—Oedema—Quinine—malaria	0.000246	0.00152	CcSEcCtD
Etoricoxib—Oedema—Quinidine—malaria	0.000246	0.00152	CcSEcCtD
Etoricoxib—Thrombocytopenia—Clindamycin—malaria	0.000246	0.00151	CcSEcCtD
Etoricoxib—Shock—Quinidine—malaria	0.000242	0.00149	CcSEcCtD
Etoricoxib—Shock—Quinine—malaria	0.000242	0.00149	CcSEcCtD
Etoricoxib—Nervous system disorder—Quinidine—malaria	0.000242	0.00149	CcSEcCtD
Etoricoxib—Nervous system disorder—Quinine—malaria	0.000242	0.00149	CcSEcCtD
Etoricoxib—Thrombocytopenia—Quinidine—malaria	0.000241	0.00148	CcSEcCtD
Etoricoxib—Thrombocytopenia—Quinine—malaria	0.000241	0.00148	CcSEcCtD
Etoricoxib—Palpitations—Quinidine barbiturate—malaria	0.000241	0.00148	CcSEcCtD
Etoricoxib—Palpitations—Pentoxifylline—malaria	0.00024	0.00148	CcSEcCtD
Etoricoxib—Skin disorder—Quinine—malaria	0.000239	0.00147	CcSEcCtD
Etoricoxib—Skin disorder—Quinidine—malaria	0.000239	0.00147	CcSEcCtD
Etoricoxib—Pruritus—Sulfadiazine—malaria	0.000239	0.00147	CcSEcCtD
Etoricoxib—Anorexia—Quinine—malaria	0.000235	0.00144	CcSEcCtD
Etoricoxib—Anorexia—Quinidine—malaria	0.000235	0.00144	CcSEcCtD
Etoricoxib—Insomnia—Dapsone—malaria	0.000235	0.00144	CcSEcCtD
Etoricoxib—Hypertension—Pentoxifylline—malaria	0.000235	0.00144	CcSEcCtD
Etoricoxib—Chest pain—Quinidine barbiturate—malaria	0.000232	0.00143	CcSEcCtD
Etoricoxib—Arthralgia—Quinidine barbiturate—malaria	0.000232	0.00143	CcSEcCtD
Etoricoxib—Chest pain—Pentoxifylline—malaria	0.000231	0.00142	CcSEcCtD
Etoricoxib—Anxiety—Quinidine barbiturate—malaria	0.000231	0.00142	CcSEcCtD
Etoricoxib—Diarrhoea—Sulfadiazine—malaria	0.000231	0.00142	CcSEcCtD
Etoricoxib—Anxiety—Pentoxifylline—malaria	0.000231	0.00142	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00023	0.00142	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00023	0.00141	CcSEcCtD
Etoricoxib—Dry mouth—Pentoxifylline—malaria	0.000226	0.00139	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Quinidine—malaria	0.000224	0.00138	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Quinine—malaria	0.000224	0.00138	CcSEcCtD
Etoricoxib—Confusional state—Quinidine barbiturate—malaria	0.000224	0.00138	CcSEcCtD
Etoricoxib—Dyspnoea—Clindamycin—malaria	0.000224	0.00138	CcSEcCtD
Etoricoxib—Confusional state—Pentoxifylline—malaria	0.000224	0.00138	CcSEcCtD
Etoricoxib—Oedema—Quinidine barbiturate—malaria	0.000222	0.00137	CcSEcCtD
Etoricoxib—Oedema—Pentoxifylline—malaria	0.000222	0.00136	CcSEcCtD
Etoricoxib—Anaphylactic shock—Pentoxifylline—malaria	0.000222	0.00136	CcSEcCtD
Etoricoxib—Dyspepsia—Clindamycin—malaria	0.000221	0.00136	CcSEcCtD
Etoricoxib—Infection—Pentoxifylline—malaria	0.00022	0.00136	CcSEcCtD
Etoricoxib—Dyspnoea—Quinine—malaria	0.00022	0.00135	CcSEcCtD
Etoricoxib—Dyspnoea—Quinidine—malaria	0.00022	0.00135	CcSEcCtD
Etoricoxib—Shock—Quinidine barbiturate—malaria	0.000219	0.00135	CcSEcCtD
Etoricoxib—Shock—Pentoxifylline—malaria	0.000218	0.00134	CcSEcCtD
Etoricoxib—Nervous system disorder—Quinidine barbiturate—malaria	0.000218	0.00134	CcSEcCtD
Etoricoxib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000218	0.00134	CcSEcCtD
Etoricoxib—Thrombocytopenia—Pentoxifylline—malaria	0.000217	0.00134	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Clindamycin—malaria	0.000217	0.00133	CcSEcCtD
Etoricoxib—Fatigue—Clindamycin—malaria	0.000216	0.00133	CcSEcCtD
Etoricoxib—Skin disorder—Quinidine barbiturate—malaria	0.000216	0.00133	CcSEcCtD
Etoricoxib—Skin disorder—Pentoxifylline—malaria	0.000216	0.00133	CcSEcCtD
Etoricoxib—Pain—Clindamycin—malaria	0.000215	0.00132	CcSEcCtD
Etoricoxib—Constipation—Clindamycin—malaria	0.000215	0.00132	CcSEcCtD
Etoricoxib—Vomiting—Sulfadiazine—malaria	0.000214	0.00132	CcSEcCtD
Etoricoxib—Decreased appetite—Quinidine—malaria	0.000214	0.00132	CcSEcCtD
Etoricoxib—Decreased appetite—Quinine—malaria	0.000214	0.00132	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Quinidine—malaria	0.000213	0.00131	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Quinine—malaria	0.000213	0.00131	CcSEcCtD
Etoricoxib—Rash—Sulfadiazine—malaria	0.000213	0.00131	CcSEcCtD
Etoricoxib—Dermatitis—Sulfadiazine—malaria	0.000212	0.00131	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Dapsone—malaria	0.000212	0.00131	CcSEcCtD
Etoricoxib—Anorexia—Quinidine barbiturate—malaria	0.000212	0.0013	CcSEcCtD
Etoricoxib—Anorexia—Pentoxifylline—malaria	0.000212	0.0013	CcSEcCtD
Etoricoxib—Headache—Sulfadiazine—malaria	0.000211	0.0013	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Clindamycin—malaria	0.000205	0.00126	CcSEcCtD
Etoricoxib—Abdominal pain—Dapsone—malaria	0.000205	0.00126	CcSEcCtD
Etoricoxib—Feeling abnormal—Quinidine—malaria	0.000203	0.00125	CcSEcCtD
Etoricoxib—Feeling abnormal—Quinine—malaria	0.000203	0.00125	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000203	0.00125	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000202	0.00124	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Quinine—malaria	0.000201	0.00124	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Quinidine—malaria	0.000201	0.00124	CcSEcCtD
Etoricoxib—Insomnia—Pentoxifylline—malaria	0.000201	0.00123	CcSEcCtD
Etoricoxib—Nausea—Sulfadiazine—malaria	0.0002	0.00123	CcSEcCtD
Etoricoxib—Urticaria—Clindamycin—malaria	0.000199	0.00123	CcSEcCtD
Etoricoxib—Abdominal pain—Clindamycin—malaria	0.000199	0.00122	CcSEcCtD
Etoricoxib—Dyspnoea—Quinidine barbiturate—malaria	0.000198	0.00122	CcSEcCtD
Etoricoxib—Dyspnoea—Pentoxifylline—malaria	0.000198	0.00122	CcSEcCtD
Etoricoxib—Somnolence—Quinidine barbiturate—malaria	0.000198	0.00122	CcSEcCtD
Etoricoxib—Somnolence—Pentoxifylline—malaria	0.000197	0.00121	CcSEcCtD
Etoricoxib—Urticaria—Quinidine—malaria	0.000196	0.0012	CcSEcCtD
Etoricoxib—Urticaria—Quinine—malaria	0.000196	0.0012	CcSEcCtD
Etoricoxib—Dyspepsia—Pentoxifylline—malaria	0.000195	0.0012	CcSEcCtD
Etoricoxib—Abdominal pain—Quinine—malaria	0.000195	0.0012	CcSEcCtD
Etoricoxib—Abdominal pain—Quinidine—malaria	0.000195	0.0012	CcSEcCtD
Etoricoxib—Decreased appetite—Quinidine barbiturate—malaria	0.000193	0.00119	CcSEcCtD
Etoricoxib—Decreased appetite—Pentoxifylline—malaria	0.000193	0.00119	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000192	0.00118	CcSEcCtD
Etoricoxib—Pain—Quinidine barbiturate—malaria	0.00019	0.00117	CcSEcCtD
Etoricoxib—Constipation—Quinidine barbiturate—malaria	0.00019	0.00117	CcSEcCtD
Etoricoxib—Constipation—Pentoxifylline—malaria	0.00019	0.00117	CcSEcCtD
Etoricoxib—Hypersensitivity—Clindamycin—malaria	0.000185	0.00114	CcSEcCtD
Etoricoxib—Feeling abnormal—Quinidine barbiturate—malaria	0.000183	0.00113	CcSEcCtD
Etoricoxib—Feeling abnormal—Pentoxifylline—malaria	0.000183	0.00112	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000182	0.00112	CcSEcCtD
Etoricoxib—Hypersensitivity—Quinidine—malaria	0.000181	0.00112	CcSEcCtD
Etoricoxib—Hypersensitivity—Quinine—malaria	0.000181	0.00112	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Pentoxifylline—malaria	0.000181	0.00112	CcSEcCtD
Etoricoxib—Asthenia—Clindamycin—malaria	0.00018	0.00111	CcSEcCtD
Etoricoxib—MAPK14—Platelet homeostasis—NOS2—malaria	0.000179	0.00437	CbGpPWpGaD
Etoricoxib—Pruritus—Clindamycin—malaria	0.000178	0.00109	CcSEcCtD
Etoricoxib—Asthenia—Quinine—malaria	0.000177	0.00109	CcSEcCtD
Etoricoxib—Asthenia—Quinidine—malaria	0.000177	0.00109	CcSEcCtD
Etoricoxib—Urticaria—Quinidine barbiturate—malaria	0.000177	0.00109	CcSEcCtD
Etoricoxib—Urticaria—Pentoxifylline—malaria	0.000176	0.00108	CcSEcCtD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000176	0.0043	CbGpPWpGaD
Etoricoxib—Abdominal pain—Quinidine barbiturate—malaria	0.000176	0.00108	CcSEcCtD
Etoricoxib—Abdominal pain—Pentoxifylline—malaria	0.000175	0.00108	CcSEcCtD
Etoricoxib—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000175	0.00429	CbGpPWpGaD
Etoricoxib—Pruritus—Quinine—malaria	0.000174	0.00107	CcSEcCtD
Etoricoxib—Pruritus—Quinidine—malaria	0.000174	0.00107	CcSEcCtD
Etoricoxib—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000173	0.00423	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—ICAM1—malaria	0.000173	0.00423	CbGpPWpGaD
Etoricoxib—Diarrhoea—Clindamycin—malaria	0.000172	0.00106	CcSEcCtD
Etoricoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000172	0.0042	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—IFNG—malaria	0.000171	0.00419	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—IFNG—malaria	0.000169	0.00413	CbGpPWpGaD
Etoricoxib—Diarrhoea—Quinine—malaria	0.000169	0.00104	CcSEcCtD
Etoricoxib—Diarrhoea—Quinidine—malaria	0.000169	0.00104	CcSEcCtD
Etoricoxib—Dizziness—Clindamycin—malaria	0.000166	0.00102	CcSEcCtD
Etoricoxib—Vomiting—Dapsone—malaria	0.000165	0.00102	CcSEcCtD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—TLR4—malaria	0.000165	0.00402	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Quinidine barbiturate—malaria	0.000164	0.00101	CcSEcCtD
Etoricoxib—Hypersensitivity—Pentoxifylline—malaria	0.000163	0.00101	CcSEcCtD
Etoricoxib—MAPK14—IL2-mediated signaling events—IL2—malaria	0.000163	0.004	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—CD4—malaria	0.000163	0.00399	CbGpPWpGaD
Etoricoxib—Dizziness—Quinidine—malaria	0.000163	0.001	CcSEcCtD
Etoricoxib—Dizziness—Quinine—malaria	0.000163	0.001	CcSEcCtD
Etoricoxib—Headache—Dapsone—malaria	0.000163	0.001	CcSEcCtD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—TLR4—malaria	0.000162	0.00396	CbGpPWpGaD
Etoricoxib—MAPK14—IL-1 signaling pathway—IL1B—malaria	0.000162	0.00395	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—CD36—malaria	0.000162	0.00395	CbGpPWpGaD
Etoricoxib—Vomiting—Clindamycin—malaria	0.00016	0.000982	CcSEcCtD
Etoricoxib—Asthenia—Quinidine barbiturate—malaria	0.00016	0.000981	CcSEcCtD
Etoricoxib—Asthenia—Pentoxifylline—malaria	0.000159	0.000979	CcSEcCtD
Etoricoxib—Rash—Clindamycin—malaria	0.000158	0.000974	CcSEcCtD
Etoricoxib—Dermatitis—Clindamycin—malaria	0.000158	0.000973	CcSEcCtD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TNF—malaria	0.000158	0.00385	CbGpPWpGaD
Etoricoxib—Headache—Clindamycin—malaria	0.000157	0.000968	CcSEcCtD
Etoricoxib—Pruritus—Quinidine barbiturate—malaria	0.000157	0.000967	CcSEcCtD
Etoricoxib—Pruritus—Pentoxifylline—malaria	0.000157	0.000966	CcSEcCtD
Etoricoxib—Vomiting—Quinine—malaria	0.000157	0.000963	CcSEcCtD
Etoricoxib—Vomiting—Quinidine—malaria	0.000157	0.000963	CcSEcCtD
Etoricoxib—Rash—Quinine—malaria	0.000155	0.000955	CcSEcCtD
Etoricoxib—Rash—Quinidine—malaria	0.000155	0.000955	CcSEcCtD
Etoricoxib—MAPK14—MyD88-independent cascade—TLR4—malaria	0.000155	0.0038	CbGpPWpGaD
Etoricoxib—Dermatitis—Quinidine—malaria	0.000155	0.000954	CcSEcCtD
Etoricoxib—Dermatitis—Quinine—malaria	0.000155	0.000954	CcSEcCtD
Etoricoxib—Headache—Quinidine—malaria	0.000154	0.000949	CcSEcCtD
Etoricoxib—Headache—Quinine—malaria	0.000154	0.000949	CcSEcCtD
Etoricoxib—Nausea—Dapsone—malaria	0.000154	0.000948	CcSEcCtD
Etoricoxib—Diarrhoea—Quinidine barbiturate—malaria	0.000152	0.000936	CcSEcCtD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—CD36—malaria	0.000152	0.00372	CbGpPWpGaD
Etoricoxib—Diarrhoea—Pentoxifylline—malaria	0.000152	0.000934	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TLR4—malaria	0.000152	0.00371	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—IL1B—malaria	0.000151	0.00369	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—IL2—malaria	0.00015	0.00367	CbGpPWpGaD
Etoricoxib—Nausea—Clindamycin—malaria	0.000149	0.000917	CcSEcCtD
Etoricoxib—Dizziness—Quinidine barbiturate—malaria	0.000147	0.000904	CcSEcCtD
Etoricoxib—Dizziness—Pentoxifylline—malaria	0.000147	0.000903	CcSEcCtD
Etoricoxib—Nausea—Quinidine—malaria	0.000146	0.0009	CcSEcCtD
Etoricoxib—Nausea—Quinine—malaria	0.000146	0.0009	CcSEcCtD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—KDR—malaria	0.000146	0.00357	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—TNF—malaria	0.000145	0.00356	CbGpPWpGaD
Etoricoxib—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000141	0.00346	CbGpPWpGaD
Etoricoxib—Vomiting—Quinidine barbiturate—malaria	0.000141	0.000869	CcSEcCtD
Etoricoxib—Vomiting—Pentoxifylline—malaria	0.000141	0.000868	CcSEcCtD
Etoricoxib—Rash—Quinidine barbiturate—malaria	0.00014	0.000862	CcSEcCtD
Etoricoxib—Dermatitis—Quinidine barbiturate—malaria	0.00014	0.000861	CcSEcCtD
Etoricoxib—Rash—Pentoxifylline—malaria	0.00014	0.000861	CcSEcCtD
Etoricoxib—Dermatitis—Pentoxifylline—malaria	0.00014	0.00086	CcSEcCtD
Etoricoxib—MAPK14—Activated TLR4 signalling—TLR4—malaria	0.00014	0.00341	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HBB—malaria	0.000139	0.00341	CbGpPWpGaD
Etoricoxib—Headache—Quinidine barbiturate—malaria	0.000139	0.000857	CcSEcCtD
Etoricoxib—MAPK14—Signalling to RAS—IL6—malaria	0.000139	0.0034	CbGpPWpGaD
Etoricoxib—Headache—Pentoxifylline—malaria	0.000139	0.000855	CcSEcCtD
Etoricoxib—MAPK14—Signaling by VEGF—KDR—malaria	0.000138	0.00337	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—CD36—malaria	0.000135	0.00331	CbGpPWpGaD
Etoricoxib—Nausea—Quinidine barbiturate—malaria	0.000132	0.000812	CcSEcCtD
Etoricoxib—Nausea—Pentoxifylline—malaria	0.000132	0.000811	CcSEcCtD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IFNG—malaria	0.000132	0.00322	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—TLR4—malaria	0.000131	0.00321	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—PKLR—malaria	0.000127	0.0031	CbGpPWpGaD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—TNF—malaria	0.000127	0.0031	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—IL1B—malaria	0.000126	0.00308	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000125	0.00305	CbGpPWpGaD
Etoricoxib—CYP1A2—Phase II conjugation—HPGDS—malaria	0.000124	0.00303	CbGpPWpGaD
Etoricoxib—CYP2E1—Biological oxidations—HPGDS—malaria	0.00012	0.00295	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TIRAP—malaria	0.00012	0.00294	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	0.00012	0.00293	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TLR4—malaria	0.000118	0.00289	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—CD4—malaria	0.000118	0.00289	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000118	0.00288	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—IL6—malaria	0.000117	0.00287	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—TNF—malaria	0.000117	0.00287	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL2—malaria	0.000117	0.00286	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—TLR4—malaria	0.000117	0.00286	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000114	0.00278	CbGpPWpGaD
Etoricoxib—MAPK14—Signalling to ERKs—IL6—malaria	0.000113	0.00277	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—FAS—malaria	0.000113	0.00276	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CR1—malaria	0.000112	0.00274	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000111	0.00271	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL1B—malaria	0.000109	0.00267	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IFNG—malaria	0.000108	0.00264	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—IL6—malaria	0.000107	0.00262	CbGpPWpGaD
Etoricoxib—MAPK14—IL6-mediated signaling events—IL6—malaria	0.000107	0.00262	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—IL2—malaria	0.000107	0.00261	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.000104	0.00255	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL4—malaria	0.000104	0.00254	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000102	0.0025	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL1B—malaria	9.86e-05	0.00241	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL1B—malaria	9.63e-05	0.00236	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR9—malaria	9.52e-05	0.00233	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—CD36—malaria	9.44e-05	0.00231	CbGpPWpGaD
Etoricoxib—MAPK14—MAP kinase activation in TLR cascade—IL6—malaria	9.33e-05	0.00228	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—HPGDS—malaria	9.29e-05	0.00227	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	8.97e-05	0.00219	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—IL6—malaria	8.95e-05	0.00219	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	8.64e-05	0.00211	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TLR4—malaria	8.61e-05	0.00211	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—HPGDS—malaria	8.55e-05	0.00209	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—HPGDS—malaria	8.47e-05	0.00207	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—malaria	8.36e-05	0.00204	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CISH—malaria	8.33e-05	0.00204	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—ICAM1—malaria	8.26e-05	0.00202	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—NOS2—malaria	8.19e-05	0.002	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	8.08e-05	0.00198	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—CD4—malaria	7.97e-05	0.00195	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IFNG—malaria	7.95e-05	0.00194	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FCGR2B—malaria	7.87e-05	0.00192	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL1B—malaria	7.7e-05	0.00188	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—FCGR2A—malaria	7.61e-05	0.00186	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	7.56e-05	0.00185	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—malaria	7.38e-05	0.00181	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—HPGDS—malaria	7.24e-05	0.00177	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—malaria	7.15e-05	0.00175	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL1B—malaria	7.09e-05	0.00173	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TIRAP—malaria	7.01e-05	0.00171	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL6—malaria	6.87e-05	0.00168	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	6.74e-05	0.00165	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	6.71e-05	0.00164	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—IL6—malaria	6.68e-05	0.00163	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—malaria	6.62e-05	0.00162	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—IL1B—malaria	6.61e-05	0.00162	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CR1—malaria	6.52e-05	0.00159	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	6.52e-05	0.00159	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—DECR1—malaria	6.51e-05	0.00159	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—IL6—malaria	6.5e-05	0.00159	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL6—malaria	6.38e-05	0.00156	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IFNG—malaria	6.28e-05	0.00154	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—malaria	6.27e-05	0.00153	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—malaria	6.16e-05	0.00151	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	5.94e-05	0.00145	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—IL6—malaria	5.91e-05	0.00145	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—malaria	5.77e-05	0.00141	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—malaria	5.64e-05	0.00138	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—malaria	5.61e-05	0.00137	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—HPGDS—malaria	5.59e-05	0.00137	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—malaria	5.59e-05	0.00137	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL2—malaria	5.58e-05	0.00137	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—malaria	5.56e-05	0.00136	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR9—malaria	5.54e-05	0.00136	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—malaria	5.32e-05	0.0013	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IL2—malaria	5.29e-05	0.00129	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—malaria	5.25e-05	0.00128	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—malaria	5.14e-05	0.00126	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	5.08e-05	0.00124	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	5e-05	0.00122	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DHODH—malaria	5e-05	0.00122	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CD36—malaria	4.96e-05	0.00121	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.91e-05	0.0012	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	4.89e-05	0.0012	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	4.89e-05	0.0012	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—CD36—malaria	4.87e-05	0.00119	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—malaria	4.8e-05	0.00117	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DHODH—malaria	4.7e-05	0.00115	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.51e-05	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—malaria	4.51e-05	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HLA-B—malaria	4.47e-05	0.00109	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—malaria	4.46e-05	0.00109	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ACKR1—malaria	4.45e-05	0.00109	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—FCGR2A—malaria	4.43e-05	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD36—malaria	4.38e-05	0.00107	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—malaria	4.33e-05	0.00106	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—KDR—malaria	4.29e-05	0.00105	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC4A1—malaria	4.25e-05	0.00104	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—malaria	4.15e-05	0.00102	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—malaria	4.07e-05	0.000995	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NOS2—malaria	4e-05	0.000979	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC4A1—malaria	4e-05	0.000978	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DECR1—malaria	3.99e-05	0.000977	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CRP—malaria	3.95e-05	0.000966	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PKLR—malaria	3.84e-05	0.00094	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—TLR4—malaria	3.79e-05	0.000926	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DECR1—malaria	3.76e-05	0.00092	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DHODH—malaria	3.63e-05	0.000887	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HBB—malaria	3.61e-05	0.000883	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TLR9—malaria	3.58e-05	0.000876	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—malaria	3.57e-05	0.000873	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.57e-05	0.000873	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—G6PD—malaria	3.43e-05	0.000838	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HBB—malaria	3.4e-05	0.000832	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DHODH—malaria	3.34e-05	0.000816	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DHODH—malaria	3.31e-05	0.000809	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—malaria	3.29e-05	0.000805	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—malaria	3.28e-05	0.000803	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.28e-05	0.000801	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.25e-05	0.000796	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PKLR—malaria	3.22e-05	0.000787	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC4A1—malaria	3.09e-05	0.000755	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PKLR—malaria	3.03e-05	0.000741	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.99e-05	0.000731	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DECR1—malaria	2.9e-05	0.000709	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—G6PD—malaria	2.87e-05	0.000702	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC4A1—malaria	2.84e-05	0.000694	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	2.83e-05	0.000692	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DHODH—malaria	2.83e-05	0.000691	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC4A1—malaria	2.81e-05	0.000688	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.78e-05	0.00068	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.77e-05	0.000677	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL18—malaria	2.75e-05	0.000672	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD40LG—malaria	2.74e-05	0.000669	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IL2—malaria	2.73e-05	0.000667	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD8A—malaria	2.71e-05	0.000662	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—G6PD—malaria	2.7e-05	0.000661	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—malaria	2.7e-05	0.00066	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CD4—malaria	2.67e-05	0.000653	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DECR1—malaria	2.67e-05	0.000653	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DECR1—malaria	2.65e-05	0.000647	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HBB—malaria	2.62e-05	0.000642	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HLA-B—malaria	2.6e-05	0.000637	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.55e-05	0.000624	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD36—malaria	2.55e-05	0.000624	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—malaria	2.53e-05	0.000619	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—DHFR—malaria	2.42e-05	0.000593	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HBB—malaria	2.41e-05	0.00059	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC4A1—malaria	2.4e-05	0.000588	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HBB—malaria	2.39e-05	0.000585	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PKLR—malaria	2.34e-05	0.000572	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—malaria	2.3e-05	0.000563	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DECR1—malaria	2.26e-05	0.000553	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TLR4—malaria	2.21e-05	0.00054	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HPGDS—malaria	2.19e-05	0.000535	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DHODH—malaria	2.18e-05	0.000534	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PKLR—malaria	2.15e-05	0.000526	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PKLR—malaria	2.13e-05	0.000521	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ICAM1—malaria	2.12e-05	0.000517	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—G6PD—malaria	2.08e-05	0.00051	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HPGDS—malaria	2.06e-05	0.000504	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	2.06e-05	0.000503	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HBB—malaria	2.04e-05	0.0005	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—DHFR—malaria	2.03e-05	0.000497	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—malaria	2.03e-05	0.000495	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SCARB1—malaria	2.01e-05	0.000491	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—G6PD—malaria	1.92e-05	0.000469	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—DHFR—malaria	1.91e-05	0.000467	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—G6PD—malaria	1.9e-05	0.000465	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SCARB1—malaria	1.89e-05	0.000463	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.88e-05	0.000459	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC4A1—malaria	1.86e-05	0.000454	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PKLR—malaria	1.82e-05	0.000446	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DECR1—malaria	1.74e-05	0.000427	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—malaria	1.63e-05	0.0004	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—G6PD—malaria	1.62e-05	0.000397	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNG—malaria	1.61e-05	0.000394	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.6e-05	0.000392	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HPGDS—malaria	1.59e-05	0.000389	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HBB—malaria	1.58e-05	0.000386	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—malaria	1.55e-05	0.00038	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—DHFR—malaria	1.47e-05	0.000361	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HPGDS—malaria	1.46e-05	0.000358	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SCARB1—malaria	1.46e-05	0.000357	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HPGDS—malaria	1.45e-05	0.000354	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—malaria	1.44e-05	0.000353	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—malaria	1.44e-05	0.000351	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—malaria	1.43e-05	0.00035	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KDR—malaria	1.43e-05	0.000349	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PKLR—malaria	1.41e-05	0.000344	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—DHFR—malaria	1.36e-05	0.000332	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—DHFR—malaria	1.34e-05	0.000329	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SCARB1—malaria	1.34e-05	0.000328	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SCARB1—malaria	1.33e-05	0.000325	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CD36—malaria	1.26e-05	0.000308	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—G6PD—malaria	1.25e-05	0.000307	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HPGDS—malaria	1.24e-05	0.000303	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS2—malaria	1.24e-05	0.000303	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CD36—malaria	1.19e-05	0.00029	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—DHFR—malaria	1.15e-05	0.000281	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SCARB1—malaria	1.14e-05	0.000278	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HPGDS—malaria	9.56e-06	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—malaria	9.25e-06	0.000226	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—malaria	9.17e-06	0.000224	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CD36—malaria	9.16e-06	0.000224	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DHFR—malaria	8.87e-06	0.000217	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SCARB1—malaria	8.78e-06	0.000215	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CD36—malaria	8.42e-06	0.000206	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—malaria	8.41e-06	0.000206	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CD36—malaria	8.35e-06	0.000204	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CD36—malaria	7.14e-06	0.000175	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CD36—malaria	5.51e-06	0.000135	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—malaria	5.44e-06	0.000133	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—malaria	4.96e-06	0.000121	CbGpPWpGaD
